自身免疫特征间质性肺炎的纤维化形态与生存
多中心回顾性队列研究对5042例特发性间质性肺炎应用IPAF标准,649例(12.9%)符合IPAF。未校正纤维化形态时IPAF分类与有利的无移植生存相关(HR 0.79;95%CI 0.68-0.92;p=0.003),校正后关联减弱(HR 0.91;95%CI 0.77-1.07;p=0.25)。校正纤维化形态后IPAF分类无预后意义,提示当前IPAF构念可能未有效识别独特人群。
要点
- IPAF分类在未校正纤维化形态时与有利无移植生存相关,校正后无预后意义。
- IPAF临床域特征在非UIP形态中可识别出类似CTD-ILD自然史的表型。
- 当前IPAF构念可能未有效识别独特人群,需结合纤维化形态评估预后。
核心结论
- 校正纤维化形态后,IPAF分类相对特发性间质性肺炎基础人群无预后意义。
- 当前IPAF构念可能未有效识别独特人群。
- IPAF临床域特征在非UIP形态中可识别出CTD-ILD样自然史表型。
研究设计与样本
- 多中心回顾性队列研究,纳入美国与英国六个特发性间质性肺炎队列共5042例。
- 应用2015年IPAF研究声明标准,649例(12.9%)符合IPAF。
- 纤维化形态通过影像和病理数据分别分析,以3年无移植生存为主要结局。
- 结局与结缔组织病相关间质性肺病参考队列(n=1566)进行基准比较。
主要发现
- 未校正影像纤维化形态时,IPAF分类与有利无移植生存相关(HR 0.79;95%CI 0.68-0.92;p=0.003)。
- 校正影像纤维化形态后关联减弱(HR 0.91;95%CI 0.77-1.07;p=0.25)。
- 校正病理纤维化形态后结果类似。
- 在常见形态组内IPAF分类无预后意义。
- 非UIP形态中,IPAF临床域特征的存在对应CTD-ILD样自然史表型。
关键数值与推荐
- IPAF标准应用后649/5042例(12.9%)符合IPAF。
- 未校正影像形态:HR 0.79(95%CI 0.68-0.92;p=0.003)。
- 校正影像形态:HR 0.91(95%CI 0.77-1.07;p=0.25)。
- CTD-ILD参考队列样本量n=1566。
临床怎么用
- 评估IPAF患者预后时需考虑 underlying 纤维化形态,而非仅依赖IPAF分类。
- 非UIP形态且具IPAF临床域特征者可按CTD-ILD样自然史管理。
- IPAF分类本身不宜单独用于预后分层。
局限性
- 回顾性队列设计。
- IPAF标准基于可用临床数据应用。
- 纤维化形态在单独分析中通过影像和病理数据确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Application of the 2015 Interstitial Pneumonia with Autoimmune Features (IPAF) research statement produced IPAF cohorts with favorable transplant-free survival (TFS) relative to the idiopathic interstitial pneumonia (IP) base populations from which they arose. Whether differences in underlying fibrotic morphology may explain this observation remains unclear.A multi-centre retrospective cohort study was performed. IPAF criteria were applied to six idiopathic IP cohorts from the US and UK using available clinical data. Fibrotic morphology was determined in separate analyses using imaging and histopathological data. Three-year TFS was compared between cohorts before and after adjustment for fibrotic morphology. Stratified analyses were performed to assess the prognostic significance of IPAF classification and presence clinical and serological domain features within key morphological groups. Outcomes were benchmarked against a connective tissue disease-associated (CTD-ILD) reference cohort (n=1566).Of 5042 individuals with idiopathic IP included in the analysis, 649 (12.9%) met IPAF criteria. Whilst IPAF classification was associated with favorable TFS before adjustment for imaging-based fibrotic morphology (HR 0.79; 95% CI 0.68-0.92; p=0.003), this association was attenuated after adjustment (HR 0.91; 95% CI 0.77-1.07; p=0.25). Results were similar when adjusting for histopathological-based morphology. IPAF classification had no prognostic significance within common morphological groups, but the presence of IPAF clinical domain features captured a phenotype with CTD-ILD-like natural history in the setting of non-UIP morphology.After accounting for differences in fibrotic morphology, IPAF classification has no prognostic significance relative to the idiopathic IP base population, suggesting that the current IPAF construct may not effectively identify a unique population.
引用
- Jee AS, Pugashetti JV, Yazbeck L, et al. Fibrotic Morphology and Survival in Interstitial Pneumonia with Autoimmune Features. Eur Respir J. 2026. PMID: 42919640. doi:10.1183/13993003.00978-2026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。